MedTrace Logo

Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial

NCT01570153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2014-03-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate the ability of a non-invasive monitor that measures how much fluid is in the body as well as various blood tests for their ability to predict worsening kidney function in patients with heart failure.

Conditions

  • Cardiorenal Syndrome
  • Acute Decompensated Heart Failure

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • James L Januzzi, MD · Cardiology Division/Cardiac Unit Associated Director Cardiac Care Unit

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-07-31
Completion
2013-11-30

Countries

  • United States
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01570153 on ClinicalTrials.gov